NCT04181567View on ClinicalTrials.gov

Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

March 3, 2014

Primary Completion Date

October 8, 2019

Study Completion Date

November 22, 2019

Conditions
Major Depressive Disorder
Interventions
OTHER

electroconvulsive therapy

electroconvulsive therapy 2 times weekly

DRUG

agomelatine

agomelatine

DRUG

Placebo

placebo

Trial Locations (1)

886

Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Department of Health, Executive Yuan, R.O.C. (Taiwan)

OTHER_GOV

collaborator

Ministry of Science and Technology, Taiwan

OTHER_GOV

lead

Kaohsiung Kai-Suan Psychiatric Hospital

OTHER_GOV

NCT04181567 - Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients | Biotech Hunter | Biotech Hunter